Moody's Investing Cash Flow decreased by 140.6% to -$91.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 140.6%, from $224.00M to -$91.00M. Over 3 years (FY 2021 to FY 2024), Investing Cash Flow shows an upward trend with a -26.1% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$57.00M | -$1.91B | -$458.00M | -$161.00M | -$11.00M | $0.00 | -$90.00M | -$63.00M | -$40.00M | -$90.00M | -$54.00M | -$96.00M | -$95.00M | -$684.00M | -$181.00M | $224.00M | -$91.00M |
| QoQ Change | — | <-999% | +76.0% | +64.8% | +93.2% | +100.0% | — | +30.0% | +36.5% | -125.0% | +40.0% | -77.8% | +1.0% | -620.0% | +73.5% | +223.8% | -140.6% |
| YoY Change | — | — | — | — | +80.7% | +100.0% | +80.3% | +60.9% | -263.6% | — | +40.0% | -52.4% | -137.5% | -660.0% | -235.2% | +333.3% | -140.6% |